免疫检查点抑制剂的抵抗机制:更新的见解
Besan H Alsaafeen1,2, Bassam R Ali3,4, Eyad Elkord5,6,7
1Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, P.O. Box: 15551, Al-Ain, United Arab Emirates.
Molecular cancer
|January 15, 2025
概括
免疫检查点抑制剂在癌症治疗中表现有前途,但面临阻力. 本综述探讨了瘤内在和外在抵抗机制,这对于改善患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了癌症治疗.
- 然而,适度的响应率受到初级或获得性耐药性的限制.
- 了解抵抗机制对于治疗进步至关重要.
研究的目的:
- 审查有关免疫检查点抑制剂耐药性机制的当前知识.
- 将抗性分为瘤内在或瘤外在的类别.
- 为了突出瘤,免疫和宿主因素之间的复杂相互作用.
主要方法:
- 对ICI耐药性研究的文献综述.
- 阻力机制的分类.
- 对瘤-免疫-宿主相互作用的分析.
主要成果:
- 对ICI的耐药性是多因素的,涉及瘤内在和外在因素.
- 主要和获得的阻力路径是不同的,但相互连接.
- 瘤微环境和宿主因素显著影响ICI疗效.
结论:
- 阐明抵抗机制是克服ICI不响应的关键.
- 向瘤内在和外在抗药途径可能会提高治疗效率.
- 考虑瘤,免疫和宿主相互作用的整体方法对于未来的策略是必要的.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
839
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
839
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469


